Development of a novel in vivo corneal fibrosis model in the dog.
about
The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review)Establishment of in vitro model of corneal scar pathophysiology.Altering equine corneal fibroblast differentiation through Smad gene transfer.Development of semi-automatic procedure for detection and tracking of fiducial markers for orofacial kinematics during natural feeding.A rabbit model of corneal Ectasia generated by treatment with collagenase type II.Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.
P2860
Development of a novel in vivo corneal fibrosis model in the dog.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development of a novel in vivo corneal fibrosis model in the dog.
@ast
Development of a novel in vivo corneal fibrosis model in the dog.
@en
type
label
Development of a novel in vivo corneal fibrosis model in the dog.
@ast
Development of a novel in vivo corneal fibrosis model in the dog.
@en
prefLabel
Development of a novel in vivo corneal fibrosis model in the dog.
@ast
Development of a novel in vivo corneal fibrosis model in the dog.
@en
P2093
P2860
P1476
Development of a novel in vivo corneal fibrosis model in the dog
@en
P2093
E A Giuliano
K M Gronkiewicz
P2860
P356
10.1016/J.EXER.2015.09.010
P577
2015-10-09T00:00:00Z